TREATMENT OF MYOCARDIAL INFARCTION USING TGF-ß ANTAGONISTS

DISCLOSED HEREIN IS A METHOD OF TREATING A PATIENT SUFFERING A MYOCARDIAL INFARCTION, PARTICULARLY AN ACUTE MYOCARDIAL INFARCTION, OR OF REDUCING AN ADVERSE CONSEQUENCE OF A MYOCARDIAL INFARCTION IN A PATIENT COMPRISING ADMINISTERING AN ANTAGONIST OF TGF-ß TO THE PATIENT DURING THE ACUTE STAGE OF TH...

Full description

Saved in:
Bibliographic Details
Main Authors GREGORY, RICHARD C., JR, LONNING, SCOTT, KUDEJ, AMELIA B, AKITA, GEOFFREY Y
Format Patent
LanguageEnglish
Published 28.02.2018
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:DISCLOSED HEREIN IS A METHOD OF TREATING A PATIENT SUFFERING A MYOCARDIAL INFARCTION, PARTICULARLY AN ACUTE MYOCARDIAL INFARCTION, OR OF REDUCING AN ADVERSE CONSEQUENCE OF A MYOCARDIAL INFARCTION IN A PATIENT COMPRISING ADMINISTERING AN ANTAGONIST OF TGF-ß TO THE PATIENT DURING THE ACUTE STAGE OF THE MYOCARDIAL INFARCTION.
Bibliography:Application Number: MY2013PI00675